Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsImmune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartmentsLicensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlNK Cells in HIV DiseaseThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?Innate immune cells in liver inflammationEvasion from NK cell-mediated immune responses by HIV-1NK Cell Influence on the Outcome of Primary Epstein-Barr Virus InfectionFeatures of Memory-Like and PD-1(+) Human NK Cell Subsetsγδ T Cells in HIV Disease: Past, Present, and FutureIL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replicationDecreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional studyLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency.HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage responseAlcohol suppresses IL-2-induced CC chemokine production by natural killer cells.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeImmune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionPersistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionUnconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicityGPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaInterferon-alpha administration enhances CD8+ T cell activation in HIV infectionIncreased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes.Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.Changes in Natural Killer cell activation and function during primary HIV-1 Infection.Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infectionNK cells and their ability to modulate T cells during virus infectionsSimian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cellsNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adultsImmune markers predictive of neuropsychiatric symptoms in HIV-infected youth.Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral ActivityImmune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressureMutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection.
P2860
Q21144323-8D986361-D134-4D89-AED2-CCD9C2E7CFC5Q21144775-EDDE0288-D8F2-493B-A5DA-58A7BC6D6021Q26747397-BA86F2C4-DDA7-451C-A377-53C9AEFD5E01Q26752833-045F846F-945B-49C8-AB9F-8181AC1F08ECQ26753146-A1CB8652-9140-4B10-8499-DF6A7A021453Q26859951-E6D9CC3F-8957-4902-ABF7-5980C3E644C1Q26864489-694E58FE-2D1D-4D61-A21A-9446358DEDCAQ28069456-9961CEF9-5973-4B91-9279-1F711663F9C4Q28073988-0E719F20-B052-4494-8F47-8A1AE46951B6Q28084822-4921E1E9-BF7D-495E-8F5B-64BFBC7F8D36Q28271479-21A43B97-D7F4-4DFC-AE7E-B19E9FF6BF4DQ28473151-B0004ED7-352B-47DC-A288-62F88A79AA88Q30845033-EE642348-8699-4E00-B3CA-43991A7C71EAQ33302895-635719DE-C080-4586-94BA-76BC1B84FDCBQ33508241-8E83AE22-DAE5-4EFC-AC3B-27176B7E943FQ33586473-27F5ADBE-BB56-4A39-88C9-65B5D260212BQ33741498-D908FEB5-E37E-425E-A3F5-315F151FF17DQ33752757-24748E3F-6D5C-40C2-959C-F9C8CA5537ACQ33772422-C8D6A90D-FEA4-4A67-9EE1-804EDE2E8FB9Q33831703-F1A7AFDA-2991-4BFE-B8F1-C667E10ABAD9Q33854427-708BAE9C-1B6E-4D5F-9193-8E5F3560E167Q33882890-5A3CC5BD-E892-45A3-B660-0D776622EAEBQ34037685-C79F55BD-E03A-45A3-AB90-1382AEEB1759Q34087961-676E2C67-F721-4C14-9BC8-2FB745B1E2DBQ34087997-78DF10EC-462F-4DE4-B38C-A9D0ECD25257Q34130226-C1DAB59D-A2C8-42D0-B2C0-E649C83CA6C2Q34145979-3ECF1790-77B7-4241-A7CD-72DABBFBC2B3Q34339253-9EFD448F-B616-4E4A-83AA-6F52425D3237Q34400439-45958278-8BDC-4556-B0A2-6ED2299AF86EQ34427488-BB803B3B-0311-4D75-94A6-A812E2972F67Q34551274-BA283381-9858-41C5-B25E-038E66BF8FB2Q34694776-122F19C1-8B95-4A61-AC5F-B7E6291EB617Q34700499-2C0D3A10-205E-46BC-8BFC-BEA1475EE0D5Q34720432-6DE2A5E3-0BD2-4FCD-A285-662D843601DFQ34741864-2DCE8D96-66EF-41FB-B318-8DF57F16A202Q34765436-9369C83A-034F-46DC-A0EF-F06C44D6D11FQ34784984-A78D0A72-00C3-4AA7-A606-73370C491E36Q34785742-18A9BF44-2F67-4DA5-B991-26A0C0748EADQ34937296-A8988289-ED17-4DC7-9EB0-234E75363039Q34959053-DC59F3C7-F795-4F29-BD6B-D8A315D6974A
P2860
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@ast
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@en
type
label
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@ast
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@en
prefLabel
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@ast
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@en
P2093
P2860
P356
P1476
Characterization of CD56-/CD16 ...... V-infected viremic individuals
@en
P2093
Alessandro Moretta
Audrey Kinter
Colin Kovacs
Dean Follman
Emanuela Marcenaro
Gabriella Lombardo
Janet Benjamin
M Angeline O'Shea
P2860
P304
P356
10.1073/PNAS.0409872102
P407
P577
2005-02-07T00:00:00Z